Prognostic factors of localized malignant melanoma: Study of 639 patients;Factores pronósticos en el melanoma maligno cutáneo localizado: Estudio de 639 pacientes

Medicina Clinica

Volumn 124, Issue 10, 2005, Pages 361-367

  Nagore Enguídanos, Eduardo ^a,d   Martínez, Vicente Oliver ^b   Botella Estrada, Rafaël ^a   Insa Mollá, Amelia ^c   Fortea Baixauli, José Miguel ^b  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d NONE   (Spain)

Author keywords

Melanoma; Prognostic factors; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RELAPSE; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; HISTOLOGY; HUMAN; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS RATE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; REPRODUCIBILITY; SPAIN; SURVIVAL RATE; THICKNESS; ULCER;

EID: 17144431382     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072569     Document Type: Article

References (40)

1. McGovern VJ, Shaw HM, Milton GW. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology. 1983;7: 673-80.
2. Thörn M, Ponten F, Bergström R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. 1994;86:761-9.
3. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reinigen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol. 2001;19:3622-34.
4. Cascinelli N, Bufalino R, Marolda R, Belli F, Nava M, Galluzzo D, et al. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Cancer. 1986;12:175-80.
5. Day CL, Harrist TJ, Gorstein F, Sober AJ, Lew RA, Friedman RJ, et al. Malignant melanoma: the prognostic significance of «microscopic satellites» in the reticular dermis and subcutaneous fat. Ann Surg. 1981;194:108-12.
6. Leon P, Daly JM, Synnestvedt M, Schultz DJ, Elder DE, Clark WH. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg. 1991;194:1461-8.
7. Harrist TJ, Rigel DS, Day CL Jr, Sober AJ, Lew RA, Rhodes AR, et al. Microscopic satellites are more highly associated with regional lymph node metastases than with primary melanoma thickness. Cancer. 1984;53:2183-7.
8. Averbook BJ, Fu P, Rao JS, Mansour EG. A long-term analysis of 1018 patients with melanoma by classic Cox regresssion and tree-structured survival analysis at a major referral center Implications on the future of cancer staging Surgery. 2002;132:589-604.
9. Masback A, Olsson H, Werterdahl J, Ingvar C, Jonsson N. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res. 2001;11:435-45.
10. Vossaert KA, Silverman MK, Kopf AW, Bart RS, Rigel DS, Friedman RJ, et al. Influence of gender on survival in patients with stage I malignant melanoma. J Am Acad Dermatol. 1992;26: 429-40.
11. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer. 1996;77:1303-10.
12. Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma. An analysis of 3661 patients from a single center. Cancer. 2003;97:1488-98.
13. MacKie RM, Aitchinson T, Sirel JM, McLaren K, Watt DC. Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database: 1979-86, and their subsequent validation. Br J Cancer. 1995;71:173-6.
14. Blois MS, Sagebiel RW, Abarbanel RM, Caldwell TM, Turtle MS. Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival. Cancer. 1983;52:1330-41.
15. Vollmer RT. Malignant melanoma. A multivariate analysis of prognostic factors. Pathol Annu. 1989;24:383-407.
16. McGovern VJ, Shaw HM, Milton GW, Farago GA. Lymphocytic infiltration and survival in malignant melanoma. En: Ackerman AB, editor. Pathology of malignant melanoma. New York: 1981; p. 341.
17. Ostmeier H, Fuchs B, Otto F, Mawick R, Lippold A, Krieg V, et al. Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma? Cancer. 1999;85:2391-9.
18. De Wit NJW, Burtscher HJ, Weidle UH, Ruiter DJ, Van Muijen GN. Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays. Melanoma Res. 2002;12:57-69.
19. Levi F, Randimbison L, La Vecchia C, Te VC, Franceschi S. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer. 1998;78:315-9.
20. Worth AJ, Gallagher RP, Elwood JM, Yang PC, Lamb C, Spinelli JJ, et al. Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. Int J Cancer. 1989;43:370-5.
21. Schmoeckel C, Bockelbrink A, Bockelbrink H, Koutsis J, Braun-Falco O. Low- and high-risk malignant melanoma - I. Evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer. 1983;19:227-35.
22. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery. 1979;86: 343-51.
23. Drzewiecki KT, Frydman H, Andersen PK, Poulsen H, Ladefoged C, Vibe P. Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982. Cancer. 1990;65:362-6.
24. Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer. 1996;78:427-32.
25. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-48.
26. Heenan PJ, Matz LR, Blackwell JB, Kelsall GRH, Seldam REJ, Holman CDJ. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia. Histopathology. 1984;8:717-29.
27. Ordóñez Gallego A, Feliu Batlle J, González Barón M. Aspectos controvertidos en el melanoma maligno cutaneo. Med Clin (Barc). 1993; 101:110-4.
28. rd ed. St. Louis: Quality Medical Publishing, Inc.; 1998. p. 103-33.
29. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970; 172:902-8.
30. Clark WH Jr, From L, Bernardino EA, Mohm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705-27.
31. McGovern VJ, Cochran AJ, Van der Esch EP, Little JH, MacLennan R. The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 classification. Pathology. 1986;18:12-21.
32. McGovern VJ, Shaw HM, Milton GW, Farago GA. Lymphocytic infiltration and survival in malignant melanoma. En: Ackerman AB, editor. Pathology of malignant melanoma. New York; 1981. p. 341.
33. Clemente C, Cook M, Ruiter DJ. Histopathologic diagnosis of melanoma. Milan: Grafiche Rekord, 1998.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1957;53:457-81.
35. Cox DR. Regression models and life tables (with discussion). J Stat Soc. 1972;34:187-200.
36. Leiter U, Buettner PG, Eigentier TK, Garbe C. Prognostic factors of thin cutaneous melanoma: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. J Clin Oncol. 2004;22:3660-7.
37. Guitart J, Lowe L, Piepkorn M, Prieto VG, Rabkin MS, Ronan SG, et al. Histological characteristics of metastasizing thin melanomas. A case-control study of 43 cases. Arch Dermatol. 2002;138: 603-8.
38. Mascara JM, Molgo M, Castel T, Castro J. Plasma cells within the infiltrate of primary cutaneous melanoma of the skin. A confirmation of its histoprognostic value. Am J Dermatopathol. 1987;9:497-9.
39. Stadelmann WK, Rapaport DP, Soong SJ, Reintgen DS, Buzaid AC, Balch CM. Prognostic clinical and pathologic features. En: Balch CM, Houghton AN, Sober AJ, Soong SJ, editors. Cutaneous melanoma. St Louis: Quality Medical Publishing, Inc.; 1998. p. 11-36.
40. Hsueh EC, Lucci A, Qi K, Morton DL. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk. Cancer. 1999;85:383-8.